Related references
Note: Only part of the references are listed.MiR-203 Participates in Human Placental Angiogenesis by Inhibiting VEGFA and VEGFR2 Expression
Fulin Liu et al.
REPRODUCTIVE SCIENCES (2018)
The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3/-CATENIN signal pathway
Xinxin Tian et al.
IUBMB LIFE (2018)
Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis
Xiyu Mei et al.
VASCULAR PHARMACOLOGY (2018)
HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells
Lumin Wang et al.
SCIENTIFIC REPORTS (2018)
Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy
Ahmed M. Abu El-Asrar et al.
ACTA OPHTHALMOLOGICA (2017)
Nogo-B Promotes Angiogenesis in Proliferative Diabetic Retinopathy via VEGF/PI3K/Akt Pathway in an Autocrine Manner
Yuelu Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia
Lingjuan Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα
Qian Chen et al.
DIABETES (2017)
MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells
Ji Hyun Chang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy
Pablo F. Barcelona et al.
JOURNAL OF NEUROSCIENCE (2016)
Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway
Jianming Wu et al.
MOLECULES (2016)
Diabetic retinopathy
Tien Y. Wong et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Retinal expression of small non-coding RNAs in a murine model of proliferative retinopathy
Chi-Hsiu Liu et al.
SCIENTIFIC REPORTS (2016)
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression
Eusebio Chiefari et al.
SCIENTIFIC REPORTS (2016)
Microarray Analysis of Gene Expression in Fibrovascular Membranes Excised From Patients With Proliferative Diabetic Retinopathy
Keijiro Ishikawa et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
Rafael Simo et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2015)
MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem cells
Jeffrey V. Brower et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Cellular Mechanisms of High Mobility Group 1 (HMGB-1) Protein Action in the Diabetic Retinopathy
Andrea Rachelle C. Santos et al.
PLOS ONE (2014)
Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism
Chen-Yuan Gong et al.
VASCULAR PHARMACOLOGY (2014)
Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
Amelie Hailer et al.
ONCOTARGET (2014)
miR-203 Suppresses Tumor Growth and Angiogenesis by Targeting VEGFA in Cervical Cancer
Xiangyu Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes
Valeria Nesca et al.
DIABETOLOGIA (2013)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With Retinopathy
Devy Deliyanti et al.
HYPERTENSION (2012)
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
Chen Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Mechanisms of Disease Diabetic Retinopathy
David A. Antonetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma
Dirk Bausch et al.
ANGIOGENESIS (2011)
MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines
Giuditta Viticchie et al.
CELL CYCLE (2011)
microRNA-203 suppresses bladder cancer development by repressing bcl-w expression
Juanjie Bo et al.
FEBS JOURNAL (2011)
Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery
Javier A. Montero et al.
CURRENT DIABETES REVIEWS (2011)
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
Elena I. Deryugina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
Mayuko Furuta et al.
CARCINOGENESIS (2010)
Surgical management of the late complications of proliferative diabetic retinopathy
D. K. Newman
EYE (2010)
RILLKKMPSV Influences the Vasculature, Neurons and Glia, and (Pro)Renin Receptor Expression in the Retina
Jennifer L. Wilkinson-Berka et al.
HYPERTENSION (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology
Jennifer L. Wilkinson Berka et al.
CIRCULATION RESEARCH (2009)
Overview of epidemiologic studies of diabetic retinopathy
Barbara Eden Kobrin Klein
OPHTHALMIC EPIDEMIOLOGY (2007)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Concept mechanisms and therapeutics of angiogenesis in cancer and other diseases
T Pralhad et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165
G Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New concepts in pathogenesis and treatment of diabetic retinopathy
J Spranger et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
NATURE MEDICINE (2000)
Share Paper
